ArticleFrontiers in oncology2022

Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance.

Mohammed Hafiz Uddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.